Procalcitonin measurement in adult clinical practice;Le dosage de la procalcitonine en pratique clinique chez l'adulte

Revue de Medecine Interne

Volumn 28, Issue 5, 2007, Pages 296-305

  Hausfater, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Fever; Outcome; Procalcitonin; Sepsis

Indexed keywords

PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADULT; BACTEREMIA; CLINICAL PRACTICE; CRITICAL ILLNESS; EARLY DIAGNOSIS; FALSE NEGATIVE RESULT; FALSE POSITIVE RESULT; FEBRILE NEUTROPENIA; FEVER; GRAM STAINING; HUMAN; INFECTION; INFLAMMATORY DISEASE; MENINGITIS; NORMAL VALUE; PARASITOSIS; PATHOPHYSIOLOGY; PROGNOSIS; SENSITIVITY AND SPECIFICITY; SEPSIS; SEPTIC SHOCK; SHORT SURVEY; SYSTEMIC LUPUS ERYTHEMATOSUS; TRANSPLANTATION; VIRUS INFECTION; BLOOD; REVIEW;

BIOLOGICAL MARKERS; CALCITONIN; HUMANS; INFECTION; PROTEIN PRECURSORS;

EID: 34247154338     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.11.003     Document Type: Short Survey

References (80)

1. Goossens H., Ferech M., Stichele R.V., Elseviers M., and ESAC Project Group. Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 365 (2005) 579-587
2. Rivers E., Nguyen B., Havstad S., Ressler J., Muzzin A., Knoblich B., et al. Early goal-directed therapy in the treatment of severe sepsis and septic shock. N. Engl. J. Med. 345 (2001) 1368-1377
3. Finney S.J., Zekveld C., Elia A., and Evans T.W. Glucose control and mortality in critically ill patients. JAMA (2003) 2041-2047
4. Annane D., Sebille V., Charpentier C., Bollaert P.E., Francois B., Korach J.M., et al. Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288 (2002) 862-871
5. Bernard G.R., Vincent J.L., Laterre P.F., LaRosa S.P., Dhainaut J.F., Lopez-Rodriguez A., et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N. Engl. J. Med. 344 (2001) 699-709
6. Assicot M., Gendrel D., Carsin H., Raymond J., Guillbaud J., and Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341 (1993) 515-518
7. Chiwakata C.B., Manegold C., Bonicke L., Waase I., Julch C., and Dietrich M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with plasmodium falciparum malaria. J. Infect. Dis. 183 (2001) 1161-1164
8. Nishikura T. Procalcitonin (PCT) production in a thyroidectomized patient. Intensive Care Med. 25 (1999) 1031
9. Oberhoffer M., Stonans I., Russwurm S., Stonane E., Vogelsang H., Junker U., et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis related cytokines in vitro. J. Lab. Clin. Med. 134 (1999) 49-55
10. Oberhoffer M., Vogelsang H., Jäger L., and Reinhart K. Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicates intracellular procalcitonin content. J. Crit. Care 14 (1999) 29-33
11. Linscheid P., Seboek D., Schaer D.J., Zulewski H., Keller U., and Müller B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and by macrophage-activated adipocytes. Crit. Care Med. 32 (2004) 1715-1721
12. Meisner M., Müller V., Khakpour Z., Toegel E., and Redl H. Induction of procalcitonin and proinflammatory cytokines in an anhepatic baboon endotoxin shock model. Shock 19 (2003) 187-190
13. Whang K.T., Vath S.D., Becker K.L., Snider R.H., Nylen E.S., and Muller B. Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock 14 (2000) 73-78
14. Dandona P., Nix D., Wilson M.F., Aljada A., Love J., Assicot M., et al. Procalcitonin increase after endotoxin injection in normal subjects. J. Clin. Endocrinol. Metab. 79 (1994) 1605-1608
15. Brunkhorst F.M., and Heinz U. Forycki. Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med. 24 (1998) 888-892
16. Nylen E.S., Whang K.T., Snider Jr. R.H., Steinwald P.M., White J.C., and Becker K.L. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit. Care Med. 26 (1998) 1001-1006
17. Becker K.L., Nylen E.S., Snider R.H., Muller B., and White J.C. Immunoneutralization of procalcitonin as therapy of sepsis. J. Endotoxin Res. 9 (2003) 367-374
18. Wiedermann F.J., Kaneider N., Egger P., Tiefenthaler W., Wiedermann C.J., Lindner K.H., et al. Migration of human monocytes in response to procalcitonin. Crit. Care Med. 30 (2002) 1112-1117
19. Hausfater P., Garric S., Ben Ayed S., Rosenheim M., Bernard M., and Riou B. Usefulness of procalcitonin as a marker of systemic infection in emergency department patients: a prospective study. Clin. Infect. Dis. 34 (2002) 895-901
20. Chan Y.L., Tseng C.P., Tsay P.K., Chang S.S., Chiu T.F., and Chen J.C. Procalcitonin as a marker of bacterial infection in the emergency department: an observational study. Crit. Care 8 (2004) R12-R20
21. Christ-Crain M., Jaccard-Stolz D., Bingisser R., Gencay M.M., Huber P.R., Tamm M., et al. Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial. Lancet 363 (2004) 600-607
22. Christ-Crain M., Stolz D., Bingisser R., Müller C., Miedinger D., Hyber P.R., et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia. Am. J. Respir. Crit. Care Med. 174 (2006) 84-93
23. Nylen E.S., Al Arifi A., Becker K.L., Snider Jr. R.H., and Alzeer A. Effect of classic heatstroke on serum procalcitonin. Crit. Care Med. 25 (1997) 1362-1365
24. Gendrel D., Raymond J., Coste J., Moulin F., Lorrot M., Guerin S., et al. Comparison of procalcitonin with C reactive protein, interleukin 6 and interferon-alpha for differentiation of bacterial vs. viral infections. Pediatr. Infect. Dis. J. 18 (1999) 875-881
25. Mimoz O., Benoist J.F., Edouard A.R., Assicot M., Bohuon C., and Samii K. Procalcitonin and C reactive protein during the early posttraumatic systemic inflammatory response syndrome. Intensive Care Med. 24 (1998) 185-188
26. Sabat R., Höflich C., Döcke W.-D., Oppert M., Kern F., Windrich B., et al. Massive elevation of procalcitonin plasma levels in the absence of infection in kidney transplant patients treated with pan-T-cell antibodies. Intensive Care Med. 27 (2001) 987-991
27. Okada Y., Minakami H., Tomomasa T., Kato M., Inoue Y., Kozawa K., et al. Serum procalcitonin concentration in patients with Kawasaki disease. J. Infect. 48 (2004) 199-205
28. Becker K.L., Snider R., Silva O.L., and Moore C.F. Calcitonin heterogeneity in lung cancer and medullary thyroid cancer. Acta Endocrinol. (Copenh.) 89 (1978) 89-99
29. Carsin H., Assicot M., Feger F., Roy O., Pennacino I., Le Bever H., et al. Evolution and significance of circulating procalcitonin levels compared with IL-6, TNF-alpha and endotoxin levels early after thermal injury. Burns 23 (1997) 218-224
30. Monneret G., Labaune J.M., Isaac C., Bienvenu F., Putet G., and Bienvenu J. Procalcitonin and C reactive protein levels in neonatal infections. Acta Paediatr. 86 (1997) 209-212
31. Ortega M., Rovira M., Filella X., Almela M., de la Bellacasa J.P., Carreras E., et al. Prospective evaluation of procalcitonin in adults with febrile neutropenia after haematopoietic stem cell transplantation. Br. J. Haematol. 126 (2004) 372-376
32. Simon A., Bijzet J., Voorbij H.A.M., Mantovani A., Van De Meer J.W.M., and Drenth J.P.H. Effect of inflammatory attacks in the classical type hyper-IgD syndrome on immunoglobulin D, cholesterol and parameters of the acute phase response. J. Intern. Med. 256 (2004) 247-253
33. Dahaba A.A., Rehak P.H., and List W.F. Procalcitonin and C reactive protein plasma concentrations in nonseptic uremic patients undergoing hemodialysis. Intensive Care Med. 29 (2003) 579-583
34. Herget-Rosenthal S., Marggraf G., Pietruck F., Hüsing J., Strupat M., Philipp T., et al. Procalcitonin for accurate detection of infection in haemodialysis. Nephrol. Dial. Transplant. 16 (2001) 975-979
35. Desvignes P., and Boutib A. Semi quantitative determination of blood procalcitonin by the immunochromatographic BRAHMS PCT-Q test: false positive result. Ann. Biol. Clin. (Paris) 63 (2005) 358-359
36. Blab E., Kohlhuber U., Tillawi S., Schweitzer M., Stangl G., Ogris E., et al. Advancements in the diagnosis of acute appendicitis in children and adolescents. Eur. J. Pediatr. Surg. 14 (2004) 404-409
37. Martinot M., Hansmann Y., De Martino S., Lesens O., Coumaros G., Pencreach E., et al. La procalcitonine dans les pyélonéphrites et les pneumopathies communautaires aiguës de l'adulte. Presse Med. 30 (2001) 1091-1096
38. Hedlund J., and Hansson L.O. Procalcitonin and C reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 28 (2000) 68-73
39. Kocazeybek B., Kucukoglu S., and Oner Y.A. Procalcitonin and C reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49 (2003) 76-84
40. Svaldi M., Hirber J., Lanthaler A.I., Mayr O., Faes S., Peer E., et al. Procalcitonin-reduced sensitivity and specificity in heavily leucopenic and immunosuppressed patients. Br. J. Haematol. 115 (2001) 53-57
41. Bernard L., Ferrière F., Casassus P., Malas F., Lévêque S., Guillevin L., et al. Procalcitonin as an early marker of bacterial infection in severely neutropenic febrile adults. Clin. Infect. Dis. 27 (1998) 914-915
42. Persson L., Engervall P., Magnuson A., Vikerfors T., Söderquist B., Hansson L.-O., et al. Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia. Scand. J. Infect. Dis. 36 (2004) 365-371
43. Giamarellou H., Giamarellou-Bourboulis E.J., Repoussis P., Galani L., Anagnostopoulos N., Grecka P., et al. Potential use of procalcitonine as a diagnostic criterion in febrile neutropenia: experience from a multicentre study. Clin. Microbiol. Infect. 10 (2004) 628-633
44. Engel A., Steinbach G., Kern P., and Kern W.V. Diagnostic value of procalcitonin serum levels in neutropenic patients with fever: comparison with interleukin-8. Scand. J. Infect. Dis. 31 (1999) 185-189
45. von Lilienfeld-Toam M., Dietrich M.P., Glasmacher A., Lehmann L., Breig P., Hahn C., et al. Markers of bacteremia in febrile neutropenic patients with hematological malignancies: procalcitonin and IL-6 are more reliable than C reactive protein. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 539-544
46. Giamarellos-Bourboulis E.J., Grecka P., Poulakou G., Anargyrou K., Katsilambros N., and Giamarellou H. Assessment of procalcitonin as a diagnostic marker of underlying infection in patients with febrile neutropenia. Clin. Infect. Dis. 32 (2001) 1125-1178
47. Simon L., Gauvin F., Amre D.K., Saint-Louis P., and Lacroix J. Serum procalcitonin and C reactive protein levels as markers of bacterial infection: a systematic review and meta-analysis. Clin. Infect. Dis. 39 (2004) 206-217
48. Eberhard O.K., Haubitz M., Brunkhorst F.M., Kliem V., Koch K.M., and Brunkhorst R. Usefulness of procalcitonin for the differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus/systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum. 40 (1997) 1250-1256
49. Shin K.C., Lee Y.J., Kang S.W., Baek H.J., Lee E.B., Kim H.A., et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann. Rheum. Dis. 60 (2001) 988-989
50. Delevaux I., André M., Colombier M., Albuisson E., Meylheuc F., Bègue R.-J., et al. Can procalcitonin measurement help in differentiating between bacterial infection and other kinds of inflammatory processes?. Ann. Rheum. Dis. 62 (2003) 337-340
51. Adam B., and Calikoglu E. Serum interleukin-6, procalcitonin and C reactive protein levels in subjects with active Behcet's disease. J. Eur. Acad. Dermatol. Venereol. 18 (2004) 318-320
52. Penel N., Fournier C., Clisant S., and N'Guyen M. Causes of fever and value of C reactive protein and procalcitonin in differentiating infections from paraneoplastic fever. Support. Care Cancer 12 (2004) 593-598
53. Jaresova M., Striz I., Cermakova J., Lacha J., Sedlacek J., Mudra K., et al. Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections. Immunol. Lett. 69 (1999) 355-358
54. Kuse E.-R., Langefeld I., Jaeger K., and Külpmann W.-R. Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit. Care Med. 28 (2000) 555-559
55. Jimeno A., Garcia-Velasco A., del Val O., Gonzalez-Billalabeitia E., Hernando S., Hernandez R., et al. Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia. Cancer 100 (2004) 2462-2469
56. Persson L., Soderquist B., Engervall P., Vikerfors T., Hansson L.O., and Tidefelt U. Assessment of systemic inflammation markers to differentiate a stable from a deteriorating clinical course in patients with febrile neutropenia. Eur. J. Haematol. 74 (2005) 297-303
57. Schwarz S., Bertram M., Schwab S., Andrassy K., and Hacke W. Serum procalcitonin levels in bacterial and abacterial meningitis. Crit. Care Med. 28 (2000) 1828-1832
58. Viallon A., Zeni F., Lambert C., Pozzetto B., Tardy B., Venet C., et al. High sensitivity and specificity of serum procalcitonin levels in adults with bacterial meningitis. Clin. Infect. Dis. 28 (1999) 1313-1316
59. Gendrel D., Raymond J., Assicot M., Moulin F., Iniguez J.-L., Lebon P., et al. Measurement of procalcitonin levels in children with bacterial or viral meningitis. Clin. Infect. Dis. 24 (1997) 1240-1242
60. Toikka P., Irjala K., Juven T., Virkki R., Mertsola J., Leinonen M., et al. Serum procalcitonin, C reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children. Pediatr. Infect. Dis. J. 19 (2000) 598-602
61. Moulin F., Raymond J., Lorrot M., Marc E., Coste J., Iniguez J.-L., et al. Procalcitonin in children admitted to hospital with community acquired pneumonia. Arch. Dis. Child. 84 (2001) 332-336
62. Aalto H., Takala A., Kautiainen H., and Repo H. Laboratory markers of systemic inflammation as predictors of bloodstream infection in acutely ill patients admitted to hospital in medical emergency. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 699-704
63. Chirouze C., Schumacher H., Rabaud C., Gil H., Khayat N., Estavoyer J.-M., et al. Low serum procalcitonin level accurately predicts the absence of bacteremia in adult patients with acute fever. Clin. Infect. Dis. 35 (2002) 156-161
64. Caterino J.M., Scheatzle M.D., Forbes M.L., and D'Antonio J.A. Bacteremic elder emergency department patients: procalcitonin and white count. Acad. Emerg. Med. 11 (2004) 393-396
65. Hausfater P., Haroche J., Juillien G., Madonna-Py B., Rozenberg F., Bernard M., et al. Intérêt du dosage couplé de la procalcitonine et de l'interféron alpha dans le diagnostic étiologique des hyperthermies aux urgences. Rev. Med. Interne 26 suppl 1 (2005) S79
66. Mueller C., Huber P., Laifer G., Mueller B., and Perruchoud A.P. Procalcitonin and the early diagnosis of infective endocarditis. Circulation 109 (2004) 1707-1710
67. de Werra I., Jaccard C., Corradin S.B., Chiolero R., Yersin B., Gallati H., et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit. Care Med. 25 (1997) 607-613
68. Müller B., Becker K.L., Schächinger H., Rickenbacher P.R., Huber P.R., Zimmerli W., et al. Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit. Care Med. 28 (2000) 977-983
69. Harbarth S., Holeckova K., Froidevaux C., Pittet D., Ricou B., Grau G.E., et al. Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis. Am. J. Respir. Crit. Care Med. 164 (2001) 396-402
70. Reinhart K., Karzai W., and Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intensive Care Med. 26 (2000) 1193-1200
71. Claeys R., Vinken S., Spapen H., ver Elst K., Decochez K., Huyghens L., et al. Plasma procalcitonin and C reactive protein in acute septic shock: clinical and biological correlates. Crit. Care Med. 30 (2002) 757-761
72. Masia M., Gutierrez F., Shum C., Padilla S., Navarro J.C., Flores E., et al. Usefulness of procalcitonin levels in community-acquired pneumonia according to the patients outcome research team pneumonia severity index. Chest 128 (2005) 2223-2229
73. van Langevelde P., Joop K., van Loon J., Frölich M., Groeneveld P.H.P., Westendorp R.G.J., et al. Endotoxin, cytokines, and procalcitonin in febrile patients admitted to the hospital: identification of subjects at high risk of mortality. Clin. Infect. Dis. 31 (2000) 1343-1348
74. Clec'h C., Ferriere F., Karoubi P., Fosse J.P., Cupa M., Hoang P., et al. Diagnostic and prognostic value of procalcitonin in patients with septic shock. Crit. Care Med. 32 (2004) 1166-1169
75. Luyt C.E., Guérin V., Combes A., Trouillet J.L., Ben Ayed S., Bernard M., et al. Procalcitonin kinetics as a prognostic marker of ventilator-associated pneumonia. Am. J. Respir. Crit. Care Med. 171 (2005) 48-53
76. Chiwakata C.B., Manegold C., Bonicke L., Waase I., Julch C., and Dietrich M. Procalcitonin as a parameter of disease severity and risk of mortality in patients with Plasmodium falciparum malaria. J. Infect. Dis. 183 (2001) 1161-1164
77. Guven H., Altintop L., Baydin A., Esen S., Aygun D., Hokelek M., et al. Diagnostic value of procalcitonin levels as an early indicator of sepsis. Am. J. Emerg. Med. 20 (2002) 202-206
78. Viallon A., Zeni F., Pouzet V., Lambert C., Quenet S., Aubert G., et al. Serum and ascitic procalcitonin levels in cirrhotic patients with spontaneous bacterial peritonitis: diagnostic value and relationship to pro-inflammatory cytokines. Intensive Care Med. 26 (2000) 1082-1088
79. Spahr L., Morard I., Hadengue A., Vadas L., and Pugin J. Procalcitonin is not an accurate marker of spontaneous bacterial peritonitis in patients with cirrhosis. Hepatogastroenterology 48 (2001) 502-505
80. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International sepsis definitions conference. Intensive Care Med. 29 (2003) 530-538